Related Experiment Video
Updated: May 8, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
Understanding HBV immunopathogenesis to inform future immune-based therapies
Margaux Bossis1, Phuong-Ha Le2, Tarik Asselah3
1Institut de Recherche Saint-Louis, Université Paris Cité, Inserm U1342, Paris, France.
Chronic hepatitis B (HBV) infection persists despite vaccines, causing liver disease. New therapies aim to restore HBV-specific immune responses for a functional cure, not just viral suppression.
Area of Science:
- Immunology
- Hepatology
- Virology
Background:
- Chronic hepatitis B virus (HBV) infection affects over 250 million globally, leading to cirrhosis and hepatocellular carcinoma (HCC).
- Current treatments suppress HBV replication but rarely achieve functional cure (sustained HBsAg loss post-treatment).
- Viral persistence is driven by intrahepatic HBV DNA and immune dysfunction.
Purpose of the Study:
- To review HBV immunopathogenesis in acute and chronic infections.
- To explore immune correlates of functional cure.
- To discuss immune-based therapies and combination strategies for HBV.
Main Methods:
- Review of current understanding of HBV immunopathogenesis.
- Analysis of immune dysfunction in chronic HBV.
- Discussion of clinical trials for immune-based therapies.
Main Results:
- HBV infection involves a tolerogenic liver microenvironment and impaired immune responses.
- Immune dysfunction includes impaired innate sensing and progressive dysfunction of HBV-specific B and T cells.
- Functional cure is associated with restored polyfunctional T cells and liver immune remodeling.
Conclusions:
- Achieving functional cure for chronic HBV requires addressing viral replication, antigen load, and immune responses.
- Combination strategies coupling antigen reduction with immune restoration are emerging.
- Durable off-treatment control necessitates a multifaceted approach targeting both the virus and the host immune system.
More Related Videos
10:37Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
Published on: October 20, 2021
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
Related Concept Videos
Hepatitis
Human Virome
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Inhibitors of Viral Protein Synthesis
Viral Hepatitis I: Introduction